Literature DB >> 15534216

Proteins of purified Epstein-Barr virus.

Eric Johannsen1, Micah Luftig, Michael R Chase, Steve Weicksel, Ellen Cahir-McFarland, Diego Illanes, David Sarracino, Elliott Kieff.   

Abstract

Mature Epstein-Barr virus (EBV) was purified from the culture medium of infected lymphocytes made functionally conditional for Zta activation of lytic replication by an in-frame fusion with a mutant estrogen receptor. Proteins in purified virus preparations were separated by gradient gel electrophoresis and trypsin-digested; peptides were then analyzed by tandem hydrophobic chromatography, tandem MS sequencing, and MS scans. Potential peptides were matched with EBV and human gene ORFs. Mature EBV was mostly composed of homologues of proteins previously found in a herpes virion. However, EBV homologues to herpes simplex virus capsid-associated or tegument components UL7 (BBRF2), UL14 (BGLF3), and EBV BFRF1 were not significantly detected. Instead, probable tegument components included the EBV and gamma-herpesvirus-encoded BLRF2, BRRF2, BDLF2 and BKRF4 proteins. Actin was also a major tegument protein, and cofilin, tubulin, heat shock protein 90, and heat shock protein 70 were substantial components. EBV envelope glycoprotein gp350 was highly abundant, followed by glycoprotein gH, intact and furin-cleaved gB, gM, gp42, gL, gp78, gp150, and gN. BILF1 (gp64) and proteins associated with latent EBV infection were not detected in virions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534216      PMCID: PMC528973          DOI: 10.1073/pnas.0407320101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Identification and characterization of the UL14 gene product of herpes simplex virus type 2.

Authors:  K Wada; F Goshima; H Takakuwa; H Yamada; T Daikoku; Y Nishiyama
Journal:  J Gen Virol       Date:  1999-09       Impact factor: 3.891

Review 2.  Two Epstein-Barr virus glycoprotein complexes.

Authors:  L M Hutt-Fletcher; C M Lake
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  Proteins associated with purified human cytomegalovirus particles.

Authors:  C J Baldick; T Shenk
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21).

Authors:  T R Serio; A Angeloni; J L Kolman; L Gradoville; R Sun; D A Katz; W Van Grunsven; J Middeldorp; G Miller
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  The product of the UL6 gene of herpes simplex virus type 1 is associated with virus capsids.

Authors:  A H Patel; J B MacLean
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

7.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid.

Authors:  W W Newcomb; R M Juhas; D R Thomsen; F L Homa; A D Burch; S K Weller; J C Brown
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).

Authors:  G T Spear; N S Lurain; C J Parker; M Ghassemi; G H Payne; M Saifuddin
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

10.  Evidence for the internal location of actin in the pseudorabies virion.

Authors:  M L Wong; C H Chen
Journal:  Virus Res       Date:  1998-08       Impact factor: 3.303

View more
  228 in total

1.  Gammaherpesvirus gene expression and DNA synthesis are facilitated by viral protein kinase and histone variant H2AX.

Authors:  Bryan C Mounce; Fei Chin Tsan; Lindsay Droit; Sarah Kohler; Justin M Reitsma; Lisa A Cirillo; Vera L Tarakanova
Journal:  Virology       Date:  2011-09-22       Impact factor: 3.616

2.  Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins.

Authors:  Chou-Wei Chang; Chung-Pei Lee; Yu-Hao Huang; Pei-Wen Yang; Jiin-Tarng Wang; Mei-Ru Chen
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Epstein-Barr Virus SM protein utilizes cellular splicing factor SRp20 to mediate alternative splicing.

Authors:  Dinesh Verma; Swarna Bais; Melusine Gaillard; Sankar Swaminathan
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

4.  Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Eric Johannsen
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

5.  Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.

Authors:  Kevin B Spurgers; Tim Alefantis; Brian D Peyser; Gordon T Ruthel; Alison A Bergeron; Julie A Costantino; Sven Enterlein; Krishna P Kota; R C Dutch Boltz; M Javad Aman; Vito G Delvecchio; Sina Bavari
Journal:  Mol Cell Proteomics       Date:  2010-08-11       Impact factor: 5.911

6.  Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle.

Authors:  Kevin Maringer; Gillian Elliott
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

Review 7.  Role of tegument proteins in herpesvirus assembly and egress.

Authors:  Haitao Guo; Sheng Shen; Lili Wang; Hongyu Deng
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

8.  Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells.

Authors:  Susan M Turk; Ru Jiang; Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Actin is a component of the compensation mechanism in pseudorabies virus virions lacking the major tegument protein VP22.

Authors:  T del Rio; C J DeCoste; L W Enquist
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

10.  The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein.

Authors:  Mindy Gore; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.